A look at three small biotech stocks seeing huge new insider buying in recent days.

The S&P 500 hit another all-time high last week as investors have become confident a Federal Reserve quarter point rate cut in on the near

As we await a new trading week to open, here are four biotech stocks garnering positive analyst commentary today.

In my over three decades of investing I have found there are two ways to beat the overall returns of the market over time.

Thanks to the $11.4 billion buyout of Array Biopharma (ARRY) by Pfizer (PFE) yesterday, the biotech sector had one of its best days in the second quarter.  T...

"Rights" are something made up by governments to make you feel like you're buying something with your taxes.” ― Stefan Molyneux Biotech was down for the seco...

The people who are crazy enough to think they can change the world are the ones who do.” ― Rob Siltanen The S&P 500 and NASDAQ both hit all-time highs again ...

The biotech and biopharma space is probably the most volatile area of the market. It is a high risk/high reward arena for aggressive growth investors. The se...